Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novavax, Inc. - Common Stock
(NQ:
NVAX
)
7.780
-0.410 (-5.01%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax, Inc. - Common Stock
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
65
66
Next >
Why Novavax Stock Fell Today
↗
October 04, 2023
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated...
Via
Benzinga
Novavax's COVID-19 Shot Just In Time, Optimism Surrounds As Demand Picks Up Momentum
↗
October 04, 2023
Tuesday, the FDA granted an emergency use nod to Novavax Inc's (NASDAQ: NVAX) COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) for active immunization to prevent COVID-19 in
Via
Benzinga
Why Is Tilray (TLRY) Stock Down 4% Today?
↗
October 04, 2023
Tilray has released its earnings report for its fiscal first quarter of 2024 and mixed results have TLRY stock on a wild ride today!
Via
InvestorPlace
These Apple Insiders Are Selling Shares of AAPL Stock
↗
October 04, 2023
Apple stock is on the move Wednesday after several insiders at the company, including CEO Tim Cook, sold shares of AAPL.
Via
InvestorPlace
Short Sellers Are Betting Against Novavax (NVAX) Stock
↗
October 04, 2023
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.
Via
InvestorPlace
Up 20% in 1 Month, Is This Stock a Buy?
↗
September 13, 2023
As Covid cases rise, Novavax is getting more attention again. But will the momentum last?
Via
The Motley Fool
What's Going On With Moderna Stock Wednesday?
↗
October 04, 2023
Moderna, Inc (NASDAQ: MRNA) shares are trading higher Wednesday.
Via
Benzinga
Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today?
↗
October 03, 2023
U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%.
Via
Benzinga
Topics
Government
Stocks
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
↗
October 03, 2023
The company can now join Pfizer and Moderna in launching an updated booster in the U.S.
Via
Investor's Business Daily
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
↗
October 03, 2023
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S.
Via
Benzinga
Why Pfizer and BioNTech Stocks Zoomed Higher Today
↗
September 29, 2023
The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.
Via
The Motley Fool
NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month
↗
September 28, 2023
With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits.
Via
InvestorPlace
Topics
Artificial Intelligence
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
↗
September 26, 2023
Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks.
Via
InvestorPlace
Does This Message From Moderna Mean Bad News for Novavax?
↗
September 21, 2023
So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market.
Via
The Motley Fool
You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10
↗
September 19, 2023
These stocks look cheap right now -- if the companies can meet their goals.
Via
The Motley Fool
Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?
↗
September 18, 2023
When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to...
Via
Benzinga
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
↗
September 15, 2023
New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get...
Via
Benzinga
Why COVID Vaccine Demand Might Not Be That Strong
↗
September 14, 2023
COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago.
Via
The Motley Fool
Novavax Is a Step Behind, Again. Should You Be Worried?
↗
September 14, 2023
The FDA still is reviewing Novavax's updated vaccine candidate.
Via
The Motley Fool
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
↗
September 12, 2023
Benzinga
Via
Benzinga
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Tending Today
↗
September 11, 2023
U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday.
Via
Benzinga
Topics
Stocks
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
↗
September 11, 2023
The U.S.
Via
Benzinga
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
↗
September 11, 2023
Novavax says it's working with the FDA to answer final requests as part of the agency's review.
Via
Investor's Business Daily
7 Biotech Stocks to Sell in September Before They Crash & Burn
↗
September 06, 2023
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues.
Via
InvestorPlace
Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry
↗
September 06, 2023
On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the...
Via
Benzinga
Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant
↗
September 06, 2023
Pirola has about 30 mutations compared with previous omicron versions of the virus.
Via
Investor's Business Daily
This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock?
↗
September 06, 2023
Today, Novavax is getting ready to compete in the fall vaccine market -- one that's in transition.
Via
The Motley Fool
Novavax, Zscaler, Digital Brands Group, Asana, Tesla: Why These 5 Stocks Are Drawing Investor Attention Today
↗
September 05, 2023
Via
Benzinga
Why Novavax Stock Rocketed 10% Higher Today
↗
September 05, 2023
The COVID vaccine maker benefits on a day when worries about a surge intensify with a new case at the White House.
Via
The Motley Fool
Why Novavax Stock Traded Higher Today
↗
September 05, 2023
Novavax, Inc. (NASDAQ: NVAX) shares trader higher Tuesday amid rising COVID cases in the US, which has lifted vaccine stocks in recent weeks.
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
65
66
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.